Devin P McAvoy

10PUBLICATIONS
120CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMedical mycologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 29, 2026
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.

|Jul 07, 2026
Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma.

|Dec 04, 2025
A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model.

Urvi A Shah, Laura Lucia Cogrossi, Juan-Jose Garcés

|Aug 27, 2025
CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia.

Mark B Geyer, Susan DeWolf, Xiaoli Mi

|Aug 25, 2025
Immune MRD Status Informs Tumor MRD Outcome Prognostication in Patients with Multiple Myeloma on Lenalidomide Maintenance.

Ross S Firestone, Anish K Simhal, Devin McAvoy

|Feb 05, 2025
Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies.

Sanam Shahid, Susan E Prockop, Georgia C Flynn

Pageof 2

Frequent Collaborators

9 joint publications

Kinga K Hosszu

8 joint publications

Sergio Giralt

8 joint publications

Gunjan Shah

7 joint publications

Heather Landau